Health News Florida4h
NIH cuts off more research funding including for vaccine hesitancy. mRNA could be next.
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
KSMU6h
NIH cuts funding for vaccine hesitancy research and may target mRNA research too
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how to increase uptake. mRNA vaccine research may be on the chopping block, too.
BioNTech price target lowered to $151 from $172 at Truist
Truist analyst Asthika Goonewardene lowered the firm’s price target on BioNTech (BNTX) to $151 from $172 and keeps a Buy rating on the shares.
BioNTech SE (BNTX) Gets a Buy from Deutsche Bank
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of ...
BioNTech SE (NASDAQ:BNTX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Welcome to BioNTech’s Fourth Quarter and Full-Year 2024 Earnings ...
Stocktwits on MSN2d
BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic
U.S.-listed shares of BioNTech SE ended Monday nearly 3.2% lower, weighed down by a weak full-year revenue projection even as ...
BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat
The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...